ClinicalTrials.gov
ClinicalTrials.gov Menu

To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01478503
Recruitment Status : Completed
First Posted : November 23, 2011
Last Update Posted : July 2, 2013
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc